RxDoctor Payments Data

Bruce Goldberg, MD

Geriatric Psychiatry · Danvers, MANPI 1568565190

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 380 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,456 and has fallen 87.5% since, to $181 in 2024. Among geriatric psychiatry clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,593in general payments, 2019–2025

Across 380 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$719
  • Takeda Pharmaceuticals U.S.A., Inc.$717
  • Sunovion Pharmaceuticals Inc.$636
  • Otsuka America Pharmaceutical, Inc.$413
  • Corium, LLC$369
  • Avanir Pharmaceuticals, Inc.$339
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$5,54699%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,593 in reported general payments places this provider in the 90th percentile of 23 geriatric psychiatry providers in Massachusetts.

See all geriatric psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$66,980
Medicare patients
144
Services billed
766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine67$4,403
Bupropion XlBupropion Hcl105$3,630
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine79$2,184
Duloxetine Hcl74$1,771
Venlafaxine Hcl ErVenlafaxine Hcl121$1,713
Escitalopram Oxalate101$1,703
Trazodone Hcl109$1,405
Methylphenidate Hcl48$1,297
Aripiprazole18$1,226
Methylphenidate ErMethylphenidate Hcl47$1,182
Clonazepam192$1,094
Sertraline Hcl87$1,092
Fluoxetine Hcl123$950
Atomoxetine Hcl12$916
Bupropion Hcl SrBupropion Hcl36$815

Paid to pharmacies, not to this prescriber.

Other geriatric psychiatry in Danvers

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →